Phase 2 Study of ART0380 Plus Gemcitabine in Platinum-Resistant Ovarian Cancers Begins 11 February 2024 | Media coverage
猫咪AV成人 Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer 7 February 2024 | Press release
New Approaches for Cancer Therapies: Targeting the DNA Damage Response 27 January 2024 | Media coverage
猫咪AV成人 Presents Positive Initial Phase 1/1b Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023 23 October 2023 | Press release
猫咪AV成人 to Present Initial Phase 1 Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023 5 October 2023 | Press release
Professor Sir Stephen Jackson receives a knighthood for services to innovation and research 19 June 2023 | Announcement
IUCT-Oncopole & 猫咪AV成人 join forces to overcome resistance to therapies for familial breast cancer 13 April 2023 | Press release